Oxygen versus air-driven nebulisers for exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial-Reference-Cited by-同舟云学术

Oxygen versus air-driven nebulisers for exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial

Published:2018-10-03 Issue:1 Volume:18 Page:
ISSN:1471-2466
Container-title:BMC Pulmonary Medicine
language:en
Short-container-title:BMC Pulm Med

Author:

Bardsley George^ORCID,Pilcher Janine^ORCID,McKinstry Steven^ORCID,Shirtcliffe Philippa^ORCID,Berry James^ORCID,Fingleton James^ORCID,Weatherall Mark^ORCID,Beasley Richard^ORCID

Funder

Health Research Council of New Zealand

Publisher

Springer Science and Business Media LLC

Subject

Pulmonary and Respiratory Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12890-018-0720-7.pdf

Reference18 articles.

1. M a A, Wills KE, Blizzard L, et al. Effect of high flow oxygen on mortality in chronic obstructive pulmonary disease patients in prehospital setting: randomised controlled trial. BMJ. 2010;341:c5462.

2. Murphy R, Driscoll P, O’Driscoll R. Emergency oxygen therapy for the COPD patient. Emerg Med J. 2001;18:333–9.

3. Edwards L, Perrin K, Williams M, et al. Randomised controlled crossover trial of the effect on PtCO2 of oxygen-driven versus air-driven nebulisers in severe chronic obstructive pulmonary disease. Emerg Med J. 2012;29:894–8.

4. Gunawardena KA, Patel B, Campbell IA, et al. Oxygen as a driving gas for nebulisers: safe or dangerous? Br Med J (Clin Res Ed). 1984;288:272–4.

5. O'Donnell D, Kelly CP, Cotter P, Clancy L. Use of oxygen driven nebuliser delivery systems for beta-2 agonists in chronic bronchitis. Ir J Med Sci. 1985;154:198–200.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Higher versus lower fractions of inspired oxygen or targets of arterial oxygenation for adults admitted to the intensive care unit;Cochrane Database of Systematic Reviews;2023-09-13

2. Chronic Obstructive Pulmonary Disease Series Part 4: Identifying, Managing, and Preventing Exacerbations;The Senior Care Pharmacist;2023-09-01

3. Gold 2023: Highlights for primary care;npj Primary Care Respiratory Medicine;2023-07-31

4. Respiratory Care Management of COPD Exacerbations;Respiratory Care;2023-05-24

5. Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary;American Journal of Respiratory and Critical Care Medicine;2023-04-01